Abstract
Mutations in the human ether-à-go-go-related gene are linked with cardiomyocyte repolarization impairment, which, in combination with other factors, can lead to life-threatening arrhythmias. The aim of the study was to demonstrate the effect of selected mutations associated with protein trafficking problems on the action potential of the ventricular cell. To perform the simulations, the O’Hara-Rudy dynamic model was used. The modification of membrane permeability to rapid delayed rectifier current was based on data obtained from in vitro studies with the human embryonic kidney (HEK293) cell line transfected with human genes: wild type and one of the seven mutations (F805C, G601S, D456Y, I31S, R823W, F640V, and A561V). Simulations were carried out for each mutation on epicardial, endocardial, and M-cells with RR interval values of 500, 750, 1000, and 1500 ms. A positive correlation between the APD90 length and the percentage of current reduction and between APD90 and RR interval lengths was observed.
This project was financed by Polish National Centre for Research and Development LIDER project number LIDER/02/187/L-1/09.
References
1. El Harchi A, Melgari D, Zhang YH, Zhang H, Hancox JC. Action potential clamp and pharmacology of the variant 1 short QT syndrome T618I hERG K(+) channel. PLoS One 2012;7:1–15.10.1371/journal.pone.0052451Search in Google Scholar PubMed PubMed Central
2. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102:1178–85.10.1161/01.CIR.102.10.1178Search in Google Scholar PubMed
3. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005;2:507–17.10.1016/j.hrthm.2005.01.020Search in Google Scholar PubMed
4. Kapa S, Tester DJ, Salisbury BA, Harris-Kerr C, Pungliya MS, Alders M, et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009;120:1752–60.10.1161/CIRCULATIONAHA.109.863076Search in Google Scholar PubMed PubMed Central
5. Männikkö R, Overend G, Perrey C, Gavaghan CL, Valentin JP, Morten J, et al. Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel. Br J Pharmacol 2010;159:102–14.10.1111/j.1476-5381.2009.00334.xSearch in Google Scholar PubMed PubMed Central
6. Single Nucleotide Polymorphism Database. dbSNP short genetic variations. Available at: http://www.ncbi.nlm.nih.gov/projects/SNP. Accessed on 6, August 2013.Search in Google Scholar
7. Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 2006;113:365–73.10.1161/CIRCULATIONAHA.105.570200Search in Google Scholar PubMed
8. Thomas D, Kiehn J, Katus HA, Karle CA. Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing. Cardiovasc Res 2003;60:235–41.10.1016/j.cardiores.2003.08.002Search in Google Scholar PubMed
9. Etheridge SP, Compton SJ, Tristani-Firouzi M, Mason JW. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J Am Coll Cardiol 2003;42:1777–82.10.1016/j.jacc.2003.07.006Search in Google Scholar PubMed
10. Fodstad H. Genetic and functional studies of severe ventricular arrhythmias, academic dissertation. Helsinki, Finland: University of Helsinki, 2005.Search in Google Scholar
11. Grilo LS, Schläpfer J, Fellmann F, Abriel H. Patient with syncope and LQTS carrying a mutation in the PAS domain of the hERG1 channel. Ann Noninvasive Electrocardiol 2011;16:213–8.10.1111/j.1542-474X.2011.00419.xSearch in Google Scholar PubMed PubMed Central
12. Itoh T, Tanaka T, Nagai R, Kamiya T, Sawayama T, Nakayama T, et al. Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome. Hum Genet 1998;102:435–9.10.1007/s004390050717Search in Google Scholar PubMed
13. Tester DJ, Ackerman MJ. Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc Res 2005;67:388–96.10.1016/j.cardiores.2005.02.013Search in Google Scholar
14. Fijorek K, Patel N, Klima Ł, Stolarz-Skrzypek K, Kawecka-Jaszcz K, Polak S. Age and gender dependent heart rate circadian model development and performance verification on the proarrhythmic drug case study. Theor Biol Med Model 2013;10:1–11.10.1186/1742-4682-10-7Search in Google Scholar
15. Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G, et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537–47.10.1161/01.CIR.81.2.537Search in Google Scholar
16. Malpas SC, Purdie GL. Circadian variation of heart rate variability. Cardiovasc Res 1990;24:210–3.10.1093/cvr/24.3.210Search in Google Scholar
17. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996;94:2850–5.10.1161/01.CIR.94.11.2850Search in Google Scholar
18. O’Hara T, Virág L, Varró A, Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput Biol 2011;7:1–29.10.1371/journal.pcbi.1002061Search in Google Scholar
19. Glukhov AV, Fedorov VV, Lou Q, Ravikumar VK, Kalish PW, Schuessler RB, et al. Transmural dispersion of repolarization in failing and nonfailing human ventricle. Circ Res 2010;106:981–91.10.1161/CIRCRESAHA.109.204891Search in Google Scholar
20. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001;104:569–80.10.1016/S0092-8674(01)00243-4Search in Google Scholar
21. O’Hara T, Rudy Y. Arrhythmia formation in subclinical (“silent”) long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example. Heart Rhythm 2012;9:275–82.10.1016/j.hrthm.2011.09.066Search in Google Scholar PubMed PubMed Central
22. Polak S, Fijorek K, Glinka A, Wisniowska B, Mendyk A. Virtual population generator for human cardiomyocytes parameters: in silico drug cardiotoxicity assessment. Toxicol Mech Methods 2012;22:31–40.10.3109/15376516.2011.585477Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
